JPRN-UMIN000025090已完成未知
The clinical trial to evaluate the efficacy of [11C]K-2 in refractory epilepsy patients undergoing anterior temporal lobectomy - The clinical trial to evaluate the efficacy of [11C]K-2 in epilepsy patients
Yokohama City University, School of Medicine0 个研究点目标入组 8 人开始时间: 2016年12月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 8
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.patients who have significant abnormalities insides the brains 2.patients who have experienced the electric stimulation therapy 3.patients who undergo artificial dialysis 4.patients who have severe liver dysfunction 5.patients who have tatoo 6.claustrophobic patients 7.breast-feeding mothers, expecting mothers, females who desire to be a mother 8.patients who desire to bear a child within this study period 9.patients who take Fycompa 10.patients who underwent nuclear medicine examination within one-week before this registarion 11.patients who underwent other clinical trials using unapproved nuclear medicine examination within six month before this registarion 12.patients who underwent other clinical trials within 12 weeks before this registarion 13.patients whom study doctors consider unappropriate
研究者
相似试验
已完成
2 期
To study the efficacy of toothpastes in teeth sensitivityCTRI/2018/04/013038Dabur India Limited139
进行中（未招募）
Unknown
The effectiveness and safety of oral adhesive bandage for extraction wound managementWound management in tooth extractionOral HealthISRCTN11589028Wuhan University120
已完成
不适用
A clinical trial to investigate the efficacy and safety of video-laryngoscopes for education of tracheal intubatioJPRN-UMIN000011477Department of Anesthesiology and Critical Care, Hiroshima University Hospital500
招募中
3 期
Thalidomide effects in COVID-19Covid 19.Covid 19IRCT20110423006257N3Arak University of Medical Sciences66
已完成
不适用
Clinical study to evaluate the efficacy, pharmacokinetics and safety of immunoglobulin intravenous (human) 10% (NewGam) in patients with primary immunodeficiency diseasesCommon variable immunodeficiencyPrimary immunodeficiency diseases (PID)Haematological DisordersISRCTN05425999Octapharma AG (Switzerland)50